<DOC>
	<DOCNO>NCT01164384</DOCNO>
	<brief_summary>Erstes Safety Trial mit Baminercept chronischen HCV Patienten . Untersuchung des potentiell antiviralen , antiinflammatorischen Effekts sowie Modulation der hepatischen Gen-Expression . 10 Patienten , open label , 10 Wochen Therapie . Sequentielles Enrollement der ersten 4 Patienten . - Trial medicinal product</brief_summary>
	<brief_title>A Phase 1b , Single Center , Clinical Study Investigate Safety Biological Responses Baminercept Patients With Chronic HCV Hepatitis .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Inclusion criterion : Informed consent Age 1860 year Chronic HCV infection Non responder ( PegIFN alpha2/Ribavirin contain therapy ) Elevated ALT Liver biopsy screen without sings ( pre ) cirrhosis Compensated liver function Absolute neutrophil count &gt; 1500 / mm3 screen Hemoglobin &gt; 10 g/dL screening Calculated creatinine clearance &gt; 60 cc/min screen Normal TSH screen Exclusion criterion : HBV infection Evidence concomitant liver disease HCV hepatitis Evidence HCC Alphafetoprotein &gt; 20ng/ml Autoimmune Disease ANA &gt; 1/320 , document last 6 month HIV 1/2 infection ALT AST &gt; 3x ULN , alkaline phosphatase &gt; 2,5x ULN Known hypersensitivity allergy Baminercept Other clinically significant concomitant disease state Known suspect noncompliance study protocol , drug alcohol abuse Infections HCV hepatitis Clinically important chest xray abnormality screen Body mass index ( BMI ) &gt; 30kg/m2 Concomitant systemic immunosuppressive/modulating therapy Treatment anticoagulant Receipt live vaccine within 4 week prior study start Symptomatic hypogammaglobulinemia history recurrent infection Subjects history malignant disease Treatment investigational product participation interventional clinical trial within last 3 month Pregnancy Breastfeeding Inability refusal practice safe contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>